Eli Lilly is advancing its diabetes and obesity treatment with an oral drug, orforglipron. In an exclusive interaction, CEO ...

Many obese people report losing pleasure in eating rich foods -- something also seen in obese mice. Scientists have now discovered the reason. Long-term high-fat diets lower levels of neurotensin in ...

A personalised, treatment plan for patients with breast cancer is ... digital health specialist Sidekick and pharma group Eli Lilly. The two companies say the integrated digital therapeutic ...

Eli Lilly and Company (NYSE: LLY) today announced at a press conference in Washington, D.C., plans to bolster its domestic ... It should be used with a reduced-calorie diet and increased physical ...

A new study reveals that long-term high-fat diets reduce pleasure from eating by lowering neurotensin, a brain peptide that boosts dopamine response.

The pleasure we get from eating junk food - the dopamine rush from crunching down on salty, greasy French fries and a luscious burger - is often blamed as the cause of overeating and rising obesity ...

Mounjaro, manufactured by Lilly, may have emerged as the newest ... ideally accompanied by a healthy diet and exercise regime. For many patients, additional drugs can be added when initial ...

BP has a history in the Gulf-it's long been a leading producer with cutting-edge wells, and it's also the site of the firm's most devastating event. The 2010 Deepwater Horizon disaster killed 11 ...

Are we truly on the brink of a cure for obesity? Or could neglecting the root causes risk worsening the very problems we seek ...